Cabaletta Bio, Inc.

NASDAQ: CABA · Healthcare · Biotechnology

PublicHQ Philadelphia, PA · PhiladelphiaCIK 0001759138Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 37DQ —GM —SS 59

v0.1 · 35/100 weight · pillars only

↑ market scale, workforce scale · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$167.9M

Employees

161

Market cap

$520.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$167.9M-$167.9M2025

Operating income-$172.2M-$172.2M2025

Total assets$165.1M$165.1M2025

Liabilities$53.0M$53.0M2025

Equity$112.1M$112.1M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cabaletta Bio, Inc. earned -$167.9M in FY2025 net income.

Peers · Healthcare

Nuvectis Pharma, Inc.——Pacific Biosciences of California, Inc.55C Bright Minds Biosciences Inc.——OrthoPediatrics Corp.69B

Neighbors

Philadelphia →

Comcast Corporation$123.7B86A Carpenter Technology Corporation$2.9B81B+Aramark$18.5B64C Five Below, Inc.$4.8B77B+Axalta Coating Systems Ltd.$5.1B78B+Urban Outfitters, Inc.$6.2B72B

Key facts

CEOSteven A. Nichtberger

SectorHealthcare

IndustryBiotechnology

HeadquartersPhiladelphia, PA

ExchangeNASDAQ: CABA

Employees161

IPO date2019-10-25

Latest filings

8-K2026-06-11 8-K2026-06-03 10-Q2026-05-14 8-K2026-05-14 8-K2026-05-14 8-K2026-05-04 8-K2026-05-04 DEF 14A2026-04-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.